Latest Pfizer Inc News
Senators press Moderna CEO on COVID-19 vaccine price hike
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health, Education,...
Editorial Roundup: United States
Excerpts from recent editorials in the United States and abroad: March 15 The Washington Post on voter fraud: A 59-year-old man was arrested last week for allegedly double voting in the 2020 presidential election. Florida authorities brought the felony...
KeyCorp, Philips 66 fall; Seagen, Insulet rise
Stocks that traded heavily or had substantial price changes Monday: Seagen Inc. up $25.04 to $197.65. Pfizer is buying the biotechnology company for $43 billion. KeyCorp, down $4.28 to $11.38. Regional banks fell amid fears over their...
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 in cash for each share of Seagen Inc. Pfizer then plans to let the biotech drug...
Seagen, Union Pacific rise; Range Resources, Tegna fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Seagen Inc., up $16.79 to $178.16. Pfizer is reportedly considering buying the biotechnology company. Range Resources Corp., down $ 2.45 to $25.81. ...
Drugmaker Pfizer starts low with 2023 earnings forecast
Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment. The drugmaker also released on Tuesday an earnings forecast that starts off below analyst expectations as Pfizer begins what company...
Large corporate donations back Kentucky GOP building fund
FRANKFORT, Ky. (AP) — Kentucky's Republican Party stockpiled more than $1.7 million for its building fund, paced by a $1 million contribution from a pharmaceutical giant, as the state's dominant political party accumulates money to expand its headquarters, according to a finance report. ...
Pfizer's Paxlovid not included in China's national insurance
TAIPEI, Taiwan (AP) — Chinese health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. Paxlovid, an oral medicine...
